German Pharmaceuticals & Biotech Big Green Snowflakes

PharmaSGP Holding

Market Cap: €292.6m

Manufactures and sells over-the-counter drugs and other healthcare products in Germany.

MPH Health Care

Market Cap: €95.0m

An investment company, engages in the healthcare business in Germany.

Merck KGaA

Market Cap: €51.1b

Operates as a science and technology company in Germany.

Cantourage Group

Market Cap: €56.2m

Operates as a medical cannabis company in Europe.

Gerresheimer

Market Cap: €1.8b

Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany.

SCHOTT Pharma KGaA

Market Cap: €3.4b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.

2invest

Market Cap: €69.6m

An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.

Medigene

Market Cap: €3.1m

A biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer.

Apontis Pharma

Market Cap: €93.3m

Engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

Formycon

Market Cap: €398.2m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

SynBiotic

Market Cap: €21.2m

Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.

Epigenomics

Market Cap: €771.9k

Does not have significant operations.

Bayer

Market Cap: €20.5b

Operates as a life science company worldwide.

Evotec

Market Cap: €1.0b

Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.

Heidelberg Pharma

Market Cap: €121.6m

A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, other European countries, the United States, and internationally.

TFF Pharmaceuticals

Market Cap: €9.7m

A clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia.

bioXXmed

Market Cap: €308.2k

An investment company, invests in biotechnology or medical technology companies with equity or debt capital.

4SC

Market Cap: €27.3m

A biopharmaceutical company, engages in developing small-molecule drugs that address cancer diseases with high unmet medical needs in Germany.

Biomark Diagnostics

Market Cap: €14.1m

An oncology focused company, develops cancer diagnostic platform to detect, monitor, and treat cancer.

Biofrontera

Market Cap: €15.8m

A biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.

Vitruvia Medical

Market Cap: €2.1m

A technology company, operates in the healthcare sector.

Darwin

Market Cap: €87.0m

Operates as a biotechnology company.

Liminal BioSciences

Market Cap: €11.8m

Liminal BioSciences Inc., a development stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom.

Sangui Biotech International

Market Cap: €419.8k

Through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products.

co.don

Market Cap: €6.5m

Does not have significant operations.

INDVR Brands

Market Cap: €314.1k

Provides personnel and management resources, and infrastructure and equipment for use in production, cultivation, and dispensary operations of licensed cannabis businesses in the United States.

Paion

Market Cap: €68.5k

A specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and intensive care medicine services worldwide.

Vidac Pharma Holding

Market Cap: €31.0m

An investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases.

co.don

Market Cap: €320.7k

Does not have significant operations.

Cannovum Cannabis

Market Cap: €115.5k

Engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin.